Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of January 2022, specifically dated January 5, 2022. The filing serves to distribute a letter to shareholders authored by Chief Executive Officer Eyal Shamir, which is included as Exhibit 99.1.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disseminate a CEO letter and does not contain financial statements or quantitative performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document focuses solely on the communication of the CEO's letter to shareholders.
Guidance, Outlook, and Risks
The filing references a letter from the CEO but does not summarize its content, guidance, outlook, management commentary, risks, contingencies, or unusual items within the body of the Form 6-K. Investors must refer to Exhibit 99.1 for these details.
Key Facts for Investor Verification
- Verify the content of the CEO letter (Exhibit 99.1) for strategic updates or material disclosures.
- Confirm that no financial results were released in this specific filing.
- Note the filing date of January 5, 2022, for timing of the shareholder communication.